SYS6006

· CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYS6006, covering 2023-05-24 to 2023-05-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or More [Phase 2]